Barcelona defender Alejandro Balde may have unwittingly handed his side's Champions League opponents Atalanta some extra ...
Barcelona take on Atalanta in their final league phase match in the Champions League, knowing that a victory would ensure a ...
Barcelona and Atalanta meet in Catalonia on Wednesday for their final UEFA Champions League game of the league phase. Hansi ...
Atalanta have outperformed their expectations in the Champions League this season and will now make one final push in their ...
As FC Barcelona get set to take on Atalanta BC in the UEFA Champions League on Wednesday night at Estadi Olimpic Lluis ...
Sitting second in the UEFA Champions League table, Barcelona hope to secure not only a Round of 16 bye but a top-four ...
Barcelona and Atalanta conclude the league phase of the Champions League against one another. Barcelona vs Atalanta best bets ...
Hansi Flick is keeping Wojciech Szczesny in goal for the final match of the league phase of the Champions League on Wednesday ...
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...
Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...